100 related articles for article (PubMed ID: 14614003)
1. Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas.
Freedman RS; Vadhan-Raj S; Butts C; Savary C; Melichar B; Verschraegen C; Kavanagh JJ; Hicks ME; Levy LB; Folloder JK; Garcia ME
Clin Cancer Res; 2003 Nov; 9(14):5228-37. PubMed ID: 14614003
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
[TBL] [Abstract][Full Text] [Related]
3. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Sabbatini P; Dupont J; Aghajanian C; Derosa F; Poynor E; Anderson S; Hensley M; Livingston P; Iasonos A; Spriggs D; McGuire W; Reinartz S; Schneider S; Grande C; Lele S; Rodabaugh K; Kepner J; Ferrone S; Odunsi K
Clin Cancer Res; 2006 Sep; 12(18):5503-10. PubMed ID: 17000686
[TBL] [Abstract][Full Text] [Related]
6. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.
Ueda Y; Itoh T; Fuji N; Harada S; Fujiki H; Shimizu K; Shiozaki A; Iwamoto A; Shimizu T; Mazda O; Kimura T; Sonoda Y; Taniwaki M; Yamagishi H
Cancer Immunol Immunother; 2007 Mar; 56(3):381-9. PubMed ID: 16830156
[TBL] [Abstract][Full Text] [Related]
7. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
8. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.
Pinzon-Charry A; Maxwell T; McGuckin MA; Schmidt C; Furnival C; López JA
Breast Cancer Res; 2006; 8(1):R5. PubMed ID: 16417648
[TBL] [Abstract][Full Text] [Related]
10. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
Reich K; Hugo S; Middel P; Blaschke V; Heine A; Neumann C
Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
[TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ovarian cancer treatment.
Matsumura N; Mandai M; Hamanishi J; Yamaguchi K; Fukuhara K; Yagi H; Higuchi T; Takakura K; Fujii S
Oncol Rep; 2008 Feb; 19(2):505-15. PubMed ID: 18202801
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes.
Haenssle H; Buhl T; Knudsen S; Krueger U; Rosenberger A; Reich K; Neumann C
Exp Dermatol; 2008 Mar; 17(3):177-87. PubMed ID: 18081852
[TBL] [Abstract][Full Text] [Related]
13. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
14. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
[TBL] [Abstract][Full Text] [Related]
15. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
16. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
Chen LL; Ye F; Yu Y; Chen HZ; Zhang WW; Lü WG; Xie X
Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
[TBL] [Abstract][Full Text] [Related]
17. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.
Zou GM; Martinson J; Hu WY; Tam Y; Klingemann HG
Cancer Immunol Immunother; 2004 Aug; 53(8):681-9. PubMed ID: 15103504
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis.
Dehlin M; Bokarewa M; Rottapel R; Foster SJ; Magnusson M; Dahlberg LE; Tarkowski A
PLoS One; 2008; 3(11):e3633. PubMed ID: 18982072
[TBL] [Abstract][Full Text] [Related]
20. HBsAg loading on dendritic cells in patients with chronic hepatitis B: expressions of phenotypic molecules.
Tong HS; Zhang Y; Yuan K; Fu XW
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):56-9. PubMed ID: 16481284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]